Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-21-005869

Chief Financial Officer bought 4,500 shares at $1.15 ($5,192)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-19 Purchase : show line 1 in the form +4,500 $1.15 $5,192 146,500 D
Open-market purchases · 4,500 sh · avg $1.15 · $5,192
Loading xslF345X03/ownership.xml…